Skip to content

Read More

Seen, Heard & Whispered: Conservatives push DOJ to act on post-Dobbs attacks on the court

TRENDING:
Donald Trump
Advertisement

Articles by Tom Howell Jr.

Pfizer said its system's rebates and discounts rise just as fast for patients. "We believe the best means to address affordability of medicines is to reduce the growing out-of-pocket costs that consumers are facing due to high deductibles and coinsurance, and ensure that patients receive the benefit of rebates at the pharmacy counter," said CEO Ian C. Read. (Associated Press)

Pfizer, Novartis, Big Pharma drug companies to end price freeze, raise costs in new year

President Trump was riding high in July after a series of strident tweets and personal phone calls paid off: Pfizer, a top drug manufacturer, had decided to defer price increases for the rest of the year. He called it "great news" for American consumers, and other companies followed suit. They froze their prices while the White House worked on a prescription-pricing blueprint. But with New Year's Day looming, the freeze is thawing.

December 26, 2018
California Gov.-elect Gavin Newsom successfully campaigned on pushing the state for a sweeping, single-payer health care system. Other Democratic governors-elect are also looking to expand health care coverage and to reform the system. (Associated Press)

Democrats look to states to expand Medicare coverage

Democrats' plans for "Medicare for all" are likely to stall in a divided Congress, leaving liberal activists looking to the states in 2019, hoping newly elected progressive champions will try to push the boundaries beyond Obamacare.

December 23, 2018

CDC: Animal doctors far more likely to take own lives

Veterinarians are far more likely to take their own lives than the general population, the government said Thursday in a study that finds animal doctors' workload, high debt and easy access to pharmaceuticals are driving the alarming trend.

December 20, 2018
The HealthCare.gov website is photographed in Washington on Dec. 15, 2017. (AP Photo/Jon Elswick) ** FILE **

Obamacare fans ramp up defense of law after ruling

Obamacare supporters are shoring up their defenses after a federal judge decided to strike the law, launching an ad campaign Tuesday as blue-state attorneys set the stage for a swift appeal.

December 18, 2018
A federal judge's ruling that the Obama health care law is unconstitutional has landed like a stink bomb among Republicans. (Associated Press/File)

Obamacare ruling sets up health care fight

President Trump says a federal judge's decision to strike Obamacare in its entirety is an early Christmas gift that clears the decks for a health care plan in the new year.

December 16, 2018
This Tuesday, Oct. 23, 2018, file photo shows HealthCare.gov website on a computer screen in New York. The sign-up period for next year’s individual health insurance coverage runs from Nov. 1 to Dec. 15. Picking a plan can initially involve several trips to websites like healthcare.gov just to understand the options. Shoppers who want to stick with the same plan must scrutinize it for changes. (AP Photo/Patrick Sison)

Trump admin.: You can still shop on HealthCare.gov

The Trump administration is reminding Americans they can still sign up for Obamacare coverage even though a federal judge said Congress invalidated the law by striking its mandate to hold insurance, starting in 2019.

December 15, 2018
President Barack Obama shares a humorous moment with a group of doctors from around the country in the Oval Office, Oct. 5, 2009, prior to a health insurance reform event at the White House. (Official White House Photo by Pete Souza)

Obamacare spiked by federal judge in Texas

Obamacare is fatally flawed and should be considered null and void, a federal judge said Friday in a bombshell ruling that sides with state Republicans who argue the GOP-led Congress' decision to gut the "individual mandate" penalty for going uninsured makes the rest of the program invalid.

December 14, 2018
Rep. Mark Meadows, R-N.C., listens during questioning of Department of Justice Inspector General Michael Horowitz during a joint House Committee on the Judiciary and House Committee on Oversight and Government Reform hearing examining Horowitz's report of the FBI's Clinton email probe, on Capitol Hill, Tuesday, June 19, 2018 in Washington. (AP Photo/Jacquelyn Martin) ** FILE **

GOP investigators question need for fetal-tissue research

President Trump's biggest GOP allies pushed Thursday to discontinue the use of fetal tissue in taxpayer-funded research, saying its benefits are overblown, it offends their constituents and good alternatives seem to exist.

December 13, 2018
This Tuesday, Oct. 23, 2018, file photo shows HealthCare.gov website on a computer screen in New York. The sign-up period for next year’s individual health insurance coverage runs from Nov. 1 to Dec. 15. Picking a plan can initially involve several trips to websites like healthcare.gov just to understand the options. Shoppers who want to stick with the same plan must scrutinize it for changes. (AP Photo/Patrick Sison)

HealthCare.gov signups 500K behind last year’s pace

Roughly 500,000 fewer people have selected coverage on the main Obamacare website than at this point last year, the administration reported Wednesday, meaning sign-ups continue to lag heading into the final days of 2019 enrollment.

December 12, 2018
In this Jan. 18, 2018 photo, used needles sit in a container inside the Baltimore City Health Department's Needle Exchange Team van in Baltimore. The overdose-reversal drug is a critical tool to easing America’s coast-to-coast opioid epidemic. But not everyone on the front lines has all they need. Baltimore’s health department is rationing its supplies of naloxone because it says it can’t afford an adequate stockpile. (AP Photo/Patrick Semansky)

Naloxone maker rolls out cheaper generic, after pricing outcry

A Virginia drugmaker said Wednesday that it will roll out a far cheaper, generic version of its overdose-reversing naloxone, one month after Senate investigators accused the company of capitalizing on the U.S. opioid epidemic by dramatically hiking its price.

December 12, 2018